Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
10,417 results
- Study Using Pregnenolone to Treat Bipolar Depression: Complete Statistical AnalysisIndependent statistical analysis of Study Using Pregnenolone to Treat Bipolar Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01409096).
- Study Will Evaluate The Safety And Efficacy Of Anidulafungin In Patients With Candidemia Or Invasive Candidiasis: Complete Statistical AnalysisIndependent statistical analysis of Study Will Evaluate The Safety And Efficacy Of Anidulafungin In Patients With Candidemia Or Invasive Candidiasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Studying Amphetamine Withdrawal in Humans: Complete Statistical AnalysisIndependent statistical analysis of Studying Amphetamine Withdrawal in Humans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01215929).
- Studying T Cells in Blood and Bone Marrow Samples From Patients With Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Studying T Cells in Blood and Bone Marrow Samples From Patients With Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Studying the Effects of Natural Visual Scene Changes on Typical Adult Visual Perception: Complete Statistical AnalysisIndependent statistical analysis of Studying the Effects of Natural Visual Scene Changes on Typical Adult Visual Perception: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Studying the Impact of Product Packaging in a Virtual Store Environment: Complete Statistical AnalysisIndependent statistical analysis of Studying the Impact of Product Packaging in a Virtual Store Environment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Stylet Angle for McGrath Videolaryngoscopy: Complete Statistical AnalysisIndependent statistical analysis of Stylet Angle for McGrath Videolaryngoscopy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03000088).
- Sub-dissociative Dose Ketamine Dosing Study: Complete Statistical AnalysisIndependent statistical analysis of Sub-dissociative Dose Ketamine Dosing Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03714620).
- Sub-dissociative Ketamine for the Management of Acute Pediatric Pain: Complete Statistical AnalysisIndependent statistical analysis of Sub-dissociative Ketamine for the Management of Acute Pediatric Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01951963).
- Sub-study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Nirogacestat, Pomalidomide, and Dexamethasone in Participants With RRMM: Complete Statistical AnalysisIndependent statistical analysis of Sub-study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Nirogacestat, Pomalidomide, and Dexamethasone in Participants With RRMM: primary endpoint results, effect estimate with confidence interval, sample-size…
- Subacromial Corticosteroid Injection for Hemiplegic Shoulder Pain: Complete Statistical AnalysisIndependent statistical analysis of Subacromial Corticosteroid Injection for Hemiplegic Shoulder Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00597766).
- Subacromial Methylprednisolone Versus Ketorolac for Shoulder Impingement: Complete Statistical AnalysisIndependent statistical analysis of Subacromial Methylprednisolone Versus Ketorolac for Shoulder Impingement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03913702).
- Subclinical Cardiovascular Disease in Psoriatic Disease: Complete Statistical AnalysisIndependent statistical analysis of Subclinical Cardiovascular Disease in Psoriatic Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03228017).
- Subconjunctival Versus Direct Mitomycin C in Trabeculectomy: Complete Statistical AnalysisIndependent statistical analysis of Subconjunctival Versus Direct Mitomycin C in Trabeculectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04352660).
- Subcutaneous Fat Reduction in the Submental Area: Complete Statistical AnalysisIndependent statistical analysis of Subcutaneous Fat Reduction in the Submental Area: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02298322).
- Subcutaneous Immunotherapy in Patients Sensitized to Dermatophagoides Pteronyssinus (DPT): Complete Statistical AnalysisIndependent statistical analysis of Subcutaneous Immunotherapy in Patients Sensitized to Dermatophagoides Pteronyssinus (DPT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01489020).
- Subcutaneous Ketamine for Postoperative Pain Relief in Rwanda: Complete Statistical AnalysisIndependent statistical analysis of Subcutaneous Ketamine for Postoperative Pain Relief in Rwanda: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02514122).
- Subcutaneous Pharmacokinetics of Belatacept: Complete Statistical AnalysisIndependent statistical analysis of Subcutaneous Pharmacokinetics of Belatacept: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00569803).
- Subcutaneous Progesterone Versus Vaginal Progesterone Tablets for Luteal Phase Support in In Vitro Fertilization (IVF): Complete Statistical AnalysisIndependent statistical analysis of Subcutaneous Progesterone Versus Vaginal Progesterone Tablets for Luteal Phase Support in In Vitro Fertilization (IVF): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema: Complete Statistical AnalysisIndependent statistical analysis of Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00097695).
- Subharmonic Imaging and Pressure Estimation for Monitoring Neoadjuvant Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Subharmonic Imaging and Pressure Estimation for Monitoring Neoadjuvant Chemotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02115607).
- Sublingual vs IV Atropine Bioavailability Study: Complete Statistical AnalysisIndependent statistical analysis of Sublingual vs IV Atropine Bioavailability Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04290039).
- SubQStim: A Post-market Study of Subcutaneous Nerve Stimulation in Failed Back Surgery Syndrome (FBSS) Patients: Complete Statistical AnalysisIndependent statistical analysis of SubQStim: A Post-market Study of Subcutaneous Nerve Stimulation in Failed Back Surgery Syndrome (FBSS) Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Substudy – Low Dose of Abatacept in Subjects With Rheumatoid Arthritis: Complete Statistical AnalysisIndependent statistical analysis of Substudy - Low Dose of Abatacept in Subjects With Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SUCCEEDIndependent statistical analysis of The SUCCEED Trial of Secondary Stroke Prevention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01763203).
- Success Rate of 4 Injection Protocols for Mandibular First Molars With Symptomatic Irreversible Pulpitis: Complete Statistical AnalysisIndependent statistical analysis of Success Rate of 4 Injection Protocols for Mandibular First Molars With Symptomatic Irreversible Pulpitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Sufentanil Infusion vs Sufentanil Bolus: Complete Statistical AnalysisIndependent statistical analysis of Sufentanil Infusion vs Sufentanil Bolus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04226495).
- Sugammadex and Quantitative Monitoring in “Fast-Track Anesthesia” During Liver Transplantation: Complete Statistical AnalysisIndependent statistical analysis of Sugammadex and Quantitative Monitoring in "Fast-Track Anesthesia" During Liver Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05216991).
- Sugammadex Versus Neostigmine for Reversal of Rocuronium Neuromuscular: Complete Statistical AnalysisIndependent statistical analysis of Sugammadex Versus Neostigmine for Reversal of Rocuronium Neuromuscular: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03322657).
- SUHRIIndependent statistical analysis of The Substance Use and Health Risk Intervention (SUHRI) for Justice-involved Youth: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Suicide Prevention for Criminal Legal Involved Managed Care Subscribers: Complete Statistical AnalysisIndependent statistical analysis of Suicide Prevention for Criminal Legal Involved Managed Care Subscribers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05579600).
- Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy: Complete Statistical AnalysisIndependent statistical analysis of Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Sulforaphane as an Antagonist to Human PXR-mediated Drug-drug Interactions: Complete Statistical AnalysisIndependent statistical analysis of Sulforaphane as an Antagonist to Human PXR-mediated Drug-drug Interactions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00621309).
- Sulindac and Breast Density in Women at Risk of Developing Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sulindac and Breast Density in Women at Risk of Developing Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SUMMITIndependent statistical analysis of A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- SUMMIT-LTSIndependent statistical analysis of Long-Term Safety and Tolerability Study of NKTR-181 in Subjects With Chronic Low Back Pain or Chronic Non-Cancer Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- SUN1058Independent statistical analysis of A Study In Patients With Non-Small Cell Lung Cancer Testing If Erlotinib Plus SU011248 (Sunitinib) Is Better Than Erlotinib Alone: primary endpoint results, effect estimate with confidence interval,…
- Sunitinib and Capecitabine for First Line Colon Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sunitinib and Capecitabine for First Line Colon Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00961571).
- Sunitinib and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery: Complete Statistical AnalysisIndependent statistical analysis of Sunitinib and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Sunitinib in Recurrent and Refractory Ovarian, Fallopian Tube and Peritoneal Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Sunitinib in Recurrent and Refractory Ovarian, Fallopian Tube and Peritoneal Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Sunitinib in Treating Patients With Kidney Cancer That Cannot Be Removed by Surgery: Complete Statistical AnalysisIndependent statistical analysis of Sunitinib in Treating Patients With Kidney Cancer That Cannot Be Removed by Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Sunitinib Malate After Stereotactic Radiosurgery in Treating Patients With Newly Diagnosed Brain Metastases: Complete Statistical AnalysisIndependent statistical analysis of Sunitinib Malate After Stereotactic Radiosurgery in Treating Patients With Newly Diagnosed Brain Metastases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Sunitinib Malate in Refractory Germ Cell Tumors: Complete Statistical AnalysisIndependent statistical analysis of Sunitinib Malate in Refractory Germ Cell Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00912912).
- Sunitinib Malate in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sunitinib Malate in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Sunitinib Malate Schedule 4/2 vs. Sunitinib Malate Continuous Dosing As First-Line Therapy For Metastatic Renal Cell Cancer (RCC): Complete Statistical AnalysisIndependent statistical analysis of Sunitinib Malate Schedule 4/2 vs. Sunitinib Malate Continuous Dosing As First-Line Therapy For Metastatic Renal Cell Cancer (RCC): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Sunitinib to Treat Recurrent Brain Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sunitinib to Treat Recurrent Brain Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00923117).
- Sunovion Growth Study Pediatric Subjects With Mild Asthma & Allergic Rhinitis: Complete Statistical AnalysisIndependent statistical analysis of Sunovion Growth Study Pediatric Subjects With Mild Asthma & Allergic Rhinitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Sunshine 2 Study for Women With Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Sunshine 2 Study for Women With Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01904032).
- Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux: Complete Statistical AnalysisIndependent statistical analysis of Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01499953).